- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
AB-PMJAY provides free hospital care to 7.4 crore patients: Centre
New Delhi: As of June 30, 2024, the Ayushman Bharat Pradhan Mantri Jan Arogya Yojana (AB-PMJAY) has authorized 7.37 crore hospital admissions totalling ₹1 lakh crore, according to the latest data from the Ministry of Health. The scheme is active across 33 states and Union Territories.
According to an IANS report, the leading states in which Ayushman cards have been created under the PMJAY scheme include Madhya Pradesh with 402.5 lakh cards, Maharashtra (280 lakh), Karnataka (171.5 lakh) Jammu and Kashmir (85.9 lakh), Telangana (82.5 lakh), Tamil Nadu (73.6 lakh) and Meghalaya (19.76 lakh).
Beneficiaries eligible under the scheme can create their Ayushman card at any time throughout the year.
Eligible beneficiaries can either create the card themselves using Ayushman App or visit the nearest CSC or empanelled hospital to create their Ayushman card.
AB-PMJAY aims to provide health cover of Rs 5 lakh per family per year for secondary and tertiary care hospitalisation to approximately 55 crore beneficiaries corresponding to 12.34 crore families constituting the bottom 40 per cent of India’s population, according to official data.
Eligible beneficiaries can avail of cashless and paperless healthcare services related to hospitalisation across more than 29,000 empanelled hospitals in the country.
The cashless treatment covers all the costs related to treatment, medicines, supplies, diagnostic services, physician’s fees, room charges, surgeon charges, OT & ICU charges, etc.
The top speciality care treatments availed by beneficiaries to date are general medicine, infectious diseases, general surgery, medical oncology, ophthalmology and orthopaedics, according to the Health Ministry, IANS reported.
In the latest national master of the Health Benefit Package (HBP), the scheme provides cashless healthcare services related to 1,949 procedures across 27 medical specialities including General Medicine, Surgery, Cardiology, Oncology, etc.
Common procedures include hemodialysis, Covid-19 screening, and treatments for acute febrile illness.
The allocations for the PMJAY scheme in the Budget for 2024-25 allocation has been increased by 10 per cent to ₹7,300 crore from the revised estimate of ₹6,800 crore in 2023-24.
Overall, the Health Ministry's budget has been raised by 12.96 per cent to ₹90,958.63 crore, compared to ₹80,517.62 crore in the revised estimate for 2023-24.
As part of the healthcare package in the Budget, the government has also announced customs duty exemptions on three cancer treatment drugs -- Trastuzumab Deruxtecan, Osimertinib and Durvalumab. The move is aimed at reducing the cost of treatment for cancer patients.
Also Read:Delhi AIIMS directs to provide seamless healthcare services to AB-PMJAY beneficiaries
Kajal joined Medical Dialogue in 2019 for the Latest Health News. She has done her graduation from the University of Delhi. She mainly covers news about the Latest Healthcare. She can be contacted at editorial@medicaldialogues.in.